Page last updated: 2024-09-04

cyc 202 and Mesothelioma

cyc 202 has been researched along with Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, YY; Chuan-Hao Kao, S; Gattani, S; Griggs, K; Kirschner, MB; Klebe, S; Linton, A; McCaughan, BC; Reid, G; Schedlich, L; Srikaran, S; van Zandwijk, N	1

Other Studies

1 other study(ies) available for cyc 202 and Mesothelioma

Article	Year
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British journal of cancer, 2014, 01-21, Volume: 110, Issue:2 Topics: Apoptosis; Blood Proteins; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Cytoskeletal Proteins; DNA Repair; DNA Replication; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Molecular Targeted Therapy; Nuclear Proteins; Pleural Neoplasms; Polo-Like Kinase 1; Prognosis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Purines; Retrospective Studies; RNA Interference; Roscovitine	2014

Article

Year

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.

British journal of cancer, 2014, 01-21, Volume: 110, Issue:2

Topics: Apoptosis; Blood Proteins; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Cytoskeletal Proteins; DNA Repair; DNA Replication; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Molecular Targeted Therapy; Nuclear Proteins; Pleural Neoplasms; Polo-Like Kinase 1; Prognosis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Purines; Retrospective Studies; RNA Interference; Roscovitine

2014